462 related articles for article (PubMed ID: 17979497)
1. Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis.
Liu RM
Antioxid Redox Signal; 2008 Feb; 10(2):303-19. PubMed ID: 17979497
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor-1 and diabetic nephropathy.
Lee HB; Ha H
Nephrology (Carlton); 2005 Oct; 10 Suppl():S11-3. PubMed ID: 16174279
[TBL] [Abstract][Full Text] [Related]
3. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of plasminogen activator and plasminogen activator inhibitor during liver fibrogenesis of rats: role of stellate cells.
Zhang LP; Takahara T; Yata Y; Furui K; Jin B; Kawada N; Watanabe A
J Hepatol; 1999 Oct; 31(4):703-11. PubMed ID: 10551395
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator inhibitor-1 suppresses profibrotic responses in fibroblasts from fibrotic lungs.
Marudamuthu AS; Shetty SK; Bhandary YP; Karandashova S; Thompson M; Sathish V; Florova G; Hogan TB; Pabelick CM; Prakash YS; Tsukasaki Y; Fu J; Ikebe M; Idell S; Shetty S
J Biol Chem; 2015 Apr; 290(15):9428-41. PubMed ID: 25648892
[TBL] [Abstract][Full Text] [Related]
6. Plasminogen Activator Inhibitor Type-1 as a Regulator of Fibrosis.
Rabieian R; Boshtam M; Zareei M; Kouhpayeh S; Masoudifar A; Mirzaei H
J Cell Biochem; 2018 Jan; 119(1):17-27. PubMed ID: 28520219
[TBL] [Abstract][Full Text] [Related]
7. A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis.
Huang Y; Haraguchi M; Lawrence DA; Border WA; Yu L; Noble NA
J Clin Invest; 2003 Aug; 112(3):379-88. PubMed ID: 12897205
[TBL] [Abstract][Full Text] [Related]
8. PAI-1 in tissue fibrosis.
Ghosh AK; Vaughan DE
J Cell Physiol; 2012 Feb; 227(2):493-507. PubMed ID: 21465481
[TBL] [Abstract][Full Text] [Related]
9. Noninhibitory PAI-1 enhances plasmin-mediated matrix degradation both in vitro and in experimental nephritis.
Huang Y; Border WA; Lawrence DA; Noble NA
Kidney Int; 2006 Aug; 70(3):515-22. PubMed ID: 16788698
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator inhibitor type 1 is a potential target in renal fibrogenesis.
Rerolle JP; Hertig A; Nguyen G; Sraer JD; Rondeau EP
Kidney Int; 2000 Nov; 58(5):1841-50. PubMed ID: 11044203
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 gene deficiency attenuates TGF-beta1-induced kidney disease.
Krag S; Danielsen CC; Carmeliet P; Nyengaard J; Wogensen L
Kidney Int; 2005 Dec; 68(6):2651-66. PubMed ID: 16316341
[TBL] [Abstract][Full Text] [Related]
12. [Changes of u-PA and PAI-1 expression in the lung tissue of neonatal rats after inhaling high concentration oxygen].
Liu XY; Xue XD
Zhonghua Er Ke Za Zhi; 2008 Jun; 46(6):458-63. PubMed ID: 19099788
[TBL] [Abstract][Full Text] [Related]
13. Role of the urokinase-fibrinolytic system in epithelial-mesenchymal transition during lung injury.
Marudamuthu AS; Bhandary YP; Shetty SK; Fu J; Sathish V; Prakash Y; Shetty S
Am J Pathol; 2015 Jan; 185(1):55-68. PubMed ID: 25447049
[TBL] [Abstract][Full Text] [Related]
14. Plasminogen Activator Inhibitor Type I Controls Cardiomyocyte Transforming Growth Factor-β and Cardiac Fibrosis.
Flevaris P; Khan SS; Eren M; Schuldt AJT; Shah SJ; Lee DC; Gupta S; Shapiro AD; Burridge PW; Ghosh AK; Vaughan DE
Circulation; 2017 Aug; 136(7):664-679. PubMed ID: 28588076
[TBL] [Abstract][Full Text] [Related]
15. The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis.
Flevaris P; Vaughan D
Semin Thromb Hemost; 2017 Mar; 43(2):169-177. PubMed ID: 27556351
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen activator inhibitor-1 in kidney pathology (Review).
Małgorzewicz S; Skrzypczak-Jankun E; Jankun J
Int J Mol Med; 2013 Mar; 31(3):503-10. PubMed ID: 23314920
[TBL] [Abstract][Full Text] [Related]
17. Suppression of plasminogen activator inhibitor-1 by RNA interference attenuates pulmonary fibrosis.
Senoo T; Hattori N; Tanimoto T; Furonaka M; Ishikawa N; Fujitaka K; Haruta Y; Murai H; Yokoyama A; Kohno N
Thorax; 2010 Apr; 65(4):334-40. PubMed ID: 20388759
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells.
Gesualdo L; Ranieri E; Monno R; Rossiello MR; Colucci M; Semeraro N; Grandaliano G; Schena FP; Ursi M; Cerullo G
Kidney Int; 1999 Aug; 56(2):461-70. PubMed ID: 10432384
[TBL] [Abstract][Full Text] [Related]
19. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
20. Modulators of induction of plasminogen activator inhibitor type-1 in HepG2 cells by transforming growth factor-β.
Nakayama N; Nakamura T; Okada H; Iwaki S; Sobel BE; Fujii S
Coron Artery Dis; 2011 Nov; 22(7):468-78. PubMed ID: 21968503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
